Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

LifeStance Health (LFST) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $260.8 million.

  • LifeStance Health's Other Operating Expenses rose 1467.77% to $260.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $979.3 million, marking a year-over-year increase of 781.76%. This contributed to the annual value of $919.5 million for FY2024, which is 1025.35% up from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Other Operating Expenses is $260.8 million, which was up 1467.77% from $250.9 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Other Operating Expenses registered a high of $260.8 million during Q3 2025, and its lowest value of $111.4 million during Q1 2021.
  • In the last 5 years, LifeStance Health's Other Operating Expenses had a median value of $206.1 million in 2023 and averaged $195.5 million.
  • In the last 5 years, LifeStance Health's Other Operating Expenses skyrocketed by 23267.5% in 2021 and then surged by 379.37% in 2025.
  • LifeStance Health's Other Operating Expenses (Quarter) stood at $151.1 million in 2021, then grew by 22.8% to $185.6 million in 2022, then grew by 18.3% to $219.5 million in 2023, then rose by 5.11% to $230.7 million in 2024, then increased by 13.03% to $260.8 million in 2025.
  • Its last three reported values are $260.8 million in Q3 2025, $250.9 million for Q2 2025, and $236.9 million during Q1 2025.